CommercialPrior AuthHigh impact
Upcoming Evolent Program Enhancements for Ambetter Health Providers: Effective December 2026
Ambetter·Oncology, Orthopedics·Provider Bulletin
Effective date
Dec 1, 2026
We identified it
Aug 26, 2026
Summary
Ambetter Health is implementing two program enhancements effective December 2026: (1) Beginning December 1, Evolent will issue direct denial determinations for oncology prior authorizations that don't meet clinical criteria instead of issuing Recommended Adverse Determinations; (2) Beginning December 5, Evolent will require site-of-care selection for shoulder, hip, knee, and spine surgeries with clinical justification if hospital-based settings are chosen for outpatient-eligible procedures.
Action Required
By November 1, 2026: (1) Billing and clinical teams must update oncology prior authorization workflows to recognize that Evolent will now issue direct denials rather than Recommended Adverse Determinations (RADs) effective December 1, 2026. Train providers to expect final determinations instead of advisory recommendations. (2) By November 15, 2026: Update authorization request submission processes for orthopedic surgeries (shoulder, hip, knee, spine) to include mandatory site-of-care selection fields effective December 5, 2026. Billing team must prepare templates requiring providers to select preferred site of care and document clinical justification when hospital-based settings are chosen for outpatient-eligible procedures. (3) Ensure all staff submitting MSK authorization requests understand that final determinations will evaluate both medical necessity AND site-of-care criteria. (4) Contact Ambetter Health Provider Services (1-833-919-3213) or Evolent (1-888-999-7713) with any implementation questions. Failure to comply with new authorization submission requirements may result in claim denials or processing delays.